Clinical Trial Update: PK Study to Assess Drug-drug Interaction and QTc Between Sitravatinib and a Cocktail of Substrates [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study to assess potential drug-drug interactions and QTc effects between sitravatinib and a substrate cocktail has been completed. The t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• Sitravatinib (sitravatinib)

Snippet

Sponsor: Mirati Therapeutics Inc. | Conditions: Advanced Solid Tumor | Phase 1 | Status: COMPLETED